Heron Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.43

-0.01 (-2.00%)

As of Jun 30, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +5,244.4% upside

Low Target $15.42

Average Target $22.81

High Target $25.92

Current Price $0.43

Current
$0.43

Target
$22.81

$15.42 $22.81 avg $25.92

Scenario Analysis

Bear Case

$15.42

3,512.9%

Low target

Base Case

$22.81

+5,244.4%

Avg target

Bull Case

$25.92

+5,973.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$2.30

-81.4% from high

52-Week Low

$0.38

+11.7% from low

Target vs 52W High

$22.81

+891.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%